Xvivo Perfusion AB (STU:3XV) Change In Receivables : €-3.02 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Xvivo Perfusion AB Change In Receivables?

Xvivo Perfusion AB's change in receivables for the quarter that ended in Mar. 2024 was €-2.07 Mil. It means Xvivo Perfusion AB's Accounts Receivable increased by €2.07 Mil from Dec. 2023 to Mar. 2024 .

Xvivo Perfusion AB's change in receivables for the fiscal year that ended in Dec. 2023 was €-2.24 Mil. It means Xvivo Perfusion AB's Accounts Receivable increased by €2.24 Mil from Dec. 2022 to Dec. 2023 .

Xvivo Perfusion AB's Accounts Receivable for the quarter that ended in Mar. 2024 was €14.90 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Xvivo Perfusion AB's Days Sales Outstanding for the three months ended in Mar. 2024 was 82.71.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Xvivo Perfusion AB's liquidation value for the three months ended in Mar. 2024 was €40.87 Mil.

Xvivo Perfusion AB Change In Receivables Historical Data

The historical data trend for Xvivo Perfusion AB's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB Change In Receivables Chart

Xvivo Perfusion AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-0.05

2.02

-0.81

-2.44

-2.24

Xvivo Perfusion AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-1.29	0.15	-0.03	-1.07	-2.07

Xvivo Perfusion AB Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.02 Mil.

Xvivo Perfusion AB (STU:3XV) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Xvivo Perfusion AB's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	14.899	/	16.438	*	91
=	82.71

2. In Ben Graham's calculation of liquidation value, Xvivo Perfusion AB's accounts receivable are only considered to be worth 75% of book value:

Xvivo Perfusion AB's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	45.168	-	22.139	+	0.75 * 14.899	+	0.5 * 13.34
=	40.87

Xvivo Perfusion AB Change In Receivables Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Xvivo Perfusion AB (STU:3XV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (STU:3XV) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

XVIPF:USA XVIVO:Sweden 3XV:Germany

Address

Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14

Website

https://www.xvivoperfusion.com

Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (STU:3XV) Headlines

No Headlines